OR WAIT 15 SECS
The company released the Biopharma Compass 2.0 software, which automates workflows for high-resolution mass spectrometry.
On Jan. 24, 2017 Bruker announced the release of the Biopharma Compass 2.0 software that automates biopharmaceutical characterization (BPC) workflows for high-resolution mass spectrometry. The BPC 2.0 unifies data acquired from MALDI-TOF/TOF and ESI-UHR-QTOF mass spectrometry methods. BPC 2.0 offers a new 3D feature finder, supports 21CFR Part 11 compliance, full integration of UV and MS data, and wizards provide defining methods from acquisition to report generation. Data inspection is accelerated by automatically generated and color-coded analysis assessments.
Biopharma Compass 2.0 unifies the data acquisition, data analysis, and result reporting of biopharma workflows including:
Biopharma Compass 2.0 wizard-driven workflows allow for monoclonal antibody and antibody-drug conjugate (ADC) characterization, such as intact mass analysis, sequence errors, truncations, substitutions, and glycosylation.